CompletedNot Applicable

IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

United States8 participantsStarted 2013-10

Plain-language summary

The purpose of this study was to see if Intense Pulsed Light (IPL) can be used safely and effectively to help treat dry eyes from ocular rosacea after chronic graft-versus-host disease (GVHD). Current treatment options for this disease are limited.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ocular rosacea with inactive GVHD Exclusion Criteria: * Active GVHD * Facial laser treatment * Accutane exposure * Inability to wear sun protection factor (SPF) 30 sunscreen and avoid sun exposure * Inability to meet study requirements

What they're measuring

Number of Participants Who Responded to Intense Pulsed Light (IPL)

Timeframe: 12 months

Trial details

NCT IDNCT02066051

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-11

Results submitted2015-10-25

View on ClinicalTrials.gov More GVHD trials